-
1901
-
1902
-
1903por Omland, Lars Haukali, Farkas, Dora Körmendiné, Jepsen, Peter, Obel, Niels, Pedersen, Lars“…BACKGROUND: Hepatitis C virus (HCV) infection is associated with an increased risk of primary liver cancer; however, 5- and 10-year risk estimates are needed. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Texto -
1904por Teutsch, Suzy, Luciani, Fabio, Scheuer, Nicolas, McCredie, Luke, Hosseiny, Parastu, Rawlinson, William, Kaldor, John, Dore, Gregory J, Dolan, Kate, Ffrench, Rosemary, Lloyd, Andrew, Haber, Paul, Levy, Michael“…BACKGROUND: Hepatitis C virus (HCV) infection is common in prisoner populations, particularly those with a history of injecting drug use (IDU). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1905por Figlerowicz, Magdalena, Jackowiak, Paulina, Formanowicz, Piotr, Kędziora, Paweł, Alejska, Magdalena, Malinowska, Nelli, Błażewicz, Jacek, Figlerowicz, Marek“…Accumulating evidence suggests that certain features of hepatitis C virus (HCV), especially its high genetic variability, might be responsible for the low efficiency of anti-HCV treatment. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1906
-
1907por Du, Juan, Zhao, Fang, Zhou, Yong, Yan, Hu, Duan, Xiang-guo, Liang, Sheng-qiang, Wang, Ying-li, Fu, Qiu-xia, Wang, Xiao-hui, Peng, Jian-chun, Zhan, Lin-sheng“…BACKGROUND: The development of small molecule inhibitors of hepatitis C virus (HCV) core protein as antiviral agents has been intensively pursued as a viable strategy to eradicate HCV infection. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1908Elimination of Hepatitis C Virus from Hepatocytes by a Selective Activation of Therapeutic Moleculespor Wen, Xiaoyu, Abe, Takayuki, Kukihara, Hiroshi, Taguwa, Shuhei, Mori, Yoshio, Tani, Hideki, Kato, Nobuyuki, Suzuki, Tetsuro, Tatsumi, Masashi, Moriishi, Kohji, Matsuura, Yoshiharu“…To eliminate hepatitis C virus (HCV) from infected hepatocytes, we generated two therapeutic molecules specifically activated in cells infected with HCV. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1909por Ouwe-Missi-Oukem-Boyer, Odile, Touré Ndouo, Fousseyni S., Ollomo, Benjamin, Mezui-Me-Ndong, Jérome, Noulin, Florian, Lachard, Isabelle, Ndong-Atome, Guy-Roger, Makuwa, Maria, Roques, Pierre, Branger, Michel, Preux, Pierre-Marie, Mazier, Dominique, Bisser, Sylvie“…BACKGROUND: Areas endemic for Plasmodium falciparum, hepatitis B virus (HBV) and hepatitis C virus (HCV) overlap in many parts of sub-Saharan Africa. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1910por Rehman, Irshad-ur, Idrees, Muhammad, Ali, Muhammad, Ali, Liaqat, Butt, Sadia, Hussain, Abrar, Akbar, Haji, Afzal, Samia“…BACKGROUND: Hepatitis C virus (HCV) is one of the leading causes of viral hepatitis worldwide and its genotype 3a is predominant in vast areas of Pakistan. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1911“…Exposure to hepatitis C virus (HCV) usually results in persistent infection that often develops into chronic liver disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1912por de Almeida, Terezinha M. B., Leitão, Regina Maria C., Carrilho, Flair J., Sonohara, Shigueko“…Genetic research on fibrosis outset and its progression in chronic hepatitis (CH) by hepatitis C virus (HCV) are limited. The lack of cytogenetic data led us to investigate the presence of micronuclei (MNi), as a sign of genomic damage. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1913“…Hepatitis C virus (HCV) infects over 130 million people causing a worldwide epidemic of liver cirrhosis and hepatocellular-carcinoma. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1914“…Hepatitis C virus (HCV) NS5A protein is phosphorylated on multiple residues; however, despite extensive study, the precise identity of these sites has not been determined unambiguously. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1915“…OBJECTIVES: An estimated 150-200 million people worldwide are infected with hepatitis C. Only limited information about the epidemiology of Hepatitis C virus (HCV) infection is available. …”
Enlace del recurso
Enlace del recurso
Texto -
1916“…Numerous constraints significantly hamper the experimental study of hepatitis C virus (HCV). Robust replication in cell culture occurs with only a few strains, and is invariably accompanied by adaptive mutations that impair in vivo infectivity/replication. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1917por Ali Ashfaq, Usman, Ansar, Muhammad, Sarwar, Muhammad Tahir, Javed, Tariq, Rehman, Sidra, Riazuddin, Sheikh“…BACKGROUND: Hepatitis C Virus (HCV) infection is a major health problem throughout world that causes acute and chronic infection which resulted in liver fibrosis, hepatocellular carcinoma and death. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1918por Gangadharan, Bevin, Antrobus, Robin, Chittenden, David, Rossa, Jan, Bapat, Manisha, Klenerman, Paul, Barnes, Eleanor, Dwek, Raymond A., Zitzmann, Nicole“…Using this method, the beta chains of both complement C3 and C4 were found to decrease in serum from hepatitis C patients with cirrhosis, a change not observed previously by 2-DE. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1919“…BACKGROUND: Hepatitis C Virus (HCV) genotypes frequency is important for the predication of response to therapy and duration of treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1920“…Hepatitis C virus (HCV) belonging to the family Flaviviridae has infected 3% of the population worldwide and 6% of the population in Pakistan. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto